Scientists see iron-containing microglia in Alzheimer’s brains
21 July 2015 | By Victoria White
Examining post-mortem tissue from the brains of people with Alzheimer's disease, researchers identified iron-containing microglia in the hippocampus...
List view / Grid view
News
TRV 101 reduces amyloid beta and tau toxic aggregates in Alzheimer’s disease models
20 July 2015 | By Victoria White
TRV 101 has successfully demonstrated significant reduction in both amyloid beta and tau toxic aggregates in mouse models of Alzheimer’s Disease...
Novel treatments emerging for human mitochondrial diseases
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
Genetic markers linking risk for type 2 diabetes and Alzheimer’s identified
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
Cholesterol metabolism in immune cells linked to HIV progression
20 July 2015 | By Victoria White
Lower levels of cholesterol in certain immune cells may help explain why some HIV-infected people are able to naturally control disease progression...
Cellecta receives NIH grant to develop CRISPR knockout library of guide RNA sequences
20 July 2015 | By Victoria White
Cellecta has announced the receipt of Phase I SBIR grant funds from the NIH to further its CRISPR-mediated genome-editing library...
In Conversation – Thoughts on the current status of the sequencing industry. An interview with Jacqueline Boultwood, University of Oxford
17 July 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford...
Teva to share a case study on how Biosimilarity has supported their Biosimilar projects | Biosimilars and Biobetters
17 July 2015 | By Biosimilars and Biobetters
This year's conference will address recent regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access & global market developments...
Anti-malaria drugs could be a potential treatment for Parkinson’s disease
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
Novogen’s Anisina receives Orphan Drug Designation from FDA for neuroblastoma
16 July 2015 | By Victoria White
Novogen has received notification FDA that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma...
Achaogen awarded $4.5 million contract to advance LpxC inhibitors
16 July 2015 | By Victoria White
Achaogen has been awarded a $4.5 million contract for the discovery and development of LpxC inhibitors for the treatment of bacterial infections...
Two Stat3 inhibitors show potential in fighting brain and breast cancers
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...
New resource makes CRISPR/Cas9 technology even more user friendly
16 July 2015 | By Victoria White
Researchers have developed a user-friendly resource to accompany the powerful CRISPR/Cas9 tool, which has been widely adopted to make precise changes in DNA...
Galapagos licenses HUB Organoid Technology for use in cystic fibrosis and IBD research
15 July 2015 | By Victoria White
Galapagos has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for preclinical research in cystic fibrosis and IBD...
MUSC and Bristol-Myers Squibb announce research collaboration focused on fibrotic diseases
15 July 2015 | By Victoria White
MUSC and Bristol-Myers Squibb have entered into a research collaboration focused on fibrotic diseases, including scleroderma and renal fibrosis...